Trevena rises as Q1 loss more than halves
** Shares of drugmaker Trevena Inc TRVN.O rise 6.7% to
$1.44 premarket
** TRVN reports Q1 net loss of $7.8 mln, or $0.81/share,
versus loss of $16.4 mln or $2.48/share last year
** Says as of March 31, it had cash, cash equivalents and
marketable securities of $27.4 mln, which TRVN believes will be
sufficient to fund operations through year-end 2023
** Up to last close, stock had fallen 5.59% so far this year
(Reporting by Ashwini Raj in Bengaluru)
((Ashwini.Raj@thomsonreuters.com))
Recent news on Trevena
See all newsTrevena Inc reports results for the quarter ended in June - Earnings Summary
Trevena Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Trevena Q2 EPS USD -0.23
Brief: Trevena Announces $2M Non-Dilutive Financing Tranche And Reduction In Outstanding Liabilities In Connection With Existing Ex-Us Royalty Financing
U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone